The standard recommended dose of Unisom is one tablet at bedtime, and you should not exceed that single dose within a 24-hour period. But that simple answer hides a complication many people miss: “Unisom” is a brand name applied to products containing two entirely different drugs, each with its own dosing ceiling and risk profile. Which box you grabbed off the shelf determines what “one tablet” actually means for your body, and going beyond the labeled dose with either ingredient can cause problems that range from a miserable next-day hangover to a genuine medical emergency.
Two Drugs, One Brand Name
Unisom SleepTabs contain doxylamine succinate at 25 mg per tablet. Unisom SleepGels and SleepMinis contain diphenhydramine hydrochloride at 50 mg per capsule, while SleepMelts contain diphenhydramine at 25 mg per tablet. Both drugs are first-generation antihistamines that cause drowsiness by crossing into the brain and blocking histamine receptors there, but they are not interchangeable. Doxylamine tends to be more sedating milligram for milligram, and their side-effect profiles in overdose diverge in ways that matter.
For doxylamine-based Unisom SleepTabs, the over-the-counter label directs adults and children 12 and older to take one 25 mg tablet at bedtime. For diphenhydramine-based SleepGels, the labeled dose is one 50 mg softgel. In either case, you are not supposed to take a second dose during the same night. The labels also carry a standard advisory: if your insomnia persists for more than two weeks, stop and talk to a doctor rather than increasing the dose on your own.
Why Taking More Does Not Help You Sleep Better
A pharmacokinetic study of doxylamine found that blood levels rise in a predictable, linear fashion as the dose goes up from 12.5 mg to 25 mg, meaning doubling the dose roughly doubles the amount of drug circulating in your system.1PubMed Central. Pharmacokinetic Dose Proportionality Between Two Strengths (12.5 mg and 25 mg) of Doxylamine Hydrogen Succinate Film-Coated Tablets in Fasting State That might sound like more drug equals more sleepiness, but what actually happens is that the sedation plateaus while the side effects keep climbing. At higher doses you do not fall asleep faster or stay asleep longer in any useful way. Instead, you start piling on anticholinergic effects: dry mouth, blurred vision, urinary retention, constipation, confusion, and a next-morning grogginess that can persist well into the afternoon.
People who feel that one Unisom tablet “isn’t working anymore” are usually experiencing tolerance, not an inadequate dose. First-generation antihistamines used for sleep are known to lose effectiveness within days to weeks of nightly use. A study of antihistamine users in primary care found that those taking first-generation agents with high brain penetration had significantly greater daytime sleepiness, more cognitive failures, and higher functional impairment compared to people taking newer, less sedating antihistamines.2PubMed Central. Impact of Antihistamines on Sleep, Cognition, and Daily Functioning: Evidence From Primary and Community Care In other words, the drug stops helping your sleep while continuing to cloud your daytime thinking. Taking two or three tablets to chase the original sedation only deepens those daytime consequences without restoring the sleep benefit.
What Happens in an Overdose
Overdosing on either Unisom ingredient is genuinely dangerous. Both doxylamine and diphenhydramine produce what clinicians call anticholinergic toxicity at high doses, and the symptoms can escalate quickly from uncomfortable to life-threatening.
Doxylamine Overdose
Case reports describe severe outcomes including rhabdomyolysis, a condition in which muscle tissue breaks down and floods the bloodstream with proteins that can destroy the kidneys. One published case involved a 52-year-old man who consumed 30 doxylamine tablets in a single episode and developed severe rhabdomyolysis, acute liver failure, and acute kidney injury requiring hemodialysis and intensive care admission. Studies in the medical literature describe additional symptoms of severe doxylamine intoxication including coma, seizures, and cardiopulmonary arrest.3PubMed Central. When Overdose of Doxylamine Leads to Severe Rhabdomyolysis and Renal Failure That Requires Hemodialysis A separate case report documented a 16-year-old with doxylamine blood levels 75 times the therapeutic range who developed rhabdomyolysis even without any preceding trauma or seizure activity, suggesting the drug itself can directly damage muscle.4PubMed. Rhabdomyolysis complicating doxylamine overdose Rhabdomyolysis with secondary kidney failure is considered rare with this drug, but recognizing and treating it early is critical because the damage can become permanent.5The American Journal of the Medical Sciences. Doxylamine Overdose as a Potential Cause of Rhabdomyolysis
Diphenhydramine Overdose
Diphenhydramine toxicity follows a partly overlapping but distinct pattern. Central nervous system effects range from drowsiness and decreased alertness at lower overdose levels to hallucinations, delirium, and seizures at higher ones. Beyond the anticholinergic syndrome, diphenhydramine at toxic doses blocks sodium channels in the heart in a manner similar to tricyclic antidepressant poisoning, which can cause dangerous irregular heart rhythms and widening of the QRS complex on an electrocardiogram.6PubMed Central. Status epilepticus and wide-complex tachycardia secondary to diphenhydramine overdose Heart dysfunction is a prominent feature of diphenhydramine overdose, with cases showing impaired pumping of the left ventricle alongside those ECG changes.7PubMed Central. Assessing Cardiovascular Dysfunction Using Cardiac Strain After Diphenhydramine Overdose There is currently no specific antidote for diphenhydramine poisoning; emergency treatment relies on supportive measures and drugs like physostigmine and sodium bicarbonate to manage individual symptoms as they arise.8PubMed Central. Treating Diphenhydramine Overdose: A Literature Review of Currently Available Treatment Methods
A Particular Risk for Young Children
Because Unisom tablets look like ordinary pills and are easily accessible on nightstands and in medicine cabinets, accidental ingestion by small children is a real concern. A retrospective review of 140 unintentional pediatric doxylamine ingestions found that the children ranged in age from 6 months to 5 years. The doses accidentally consumed varied widely, with estimated maximums as high as 375 mg in some cases and weight-based doses reaching up to 37 mg/kg. Fortunately, all symptoms in this series were mild and self-limiting, with activated charcoal being the only intervention used and only in a small number of cases.9PubMed. Retrospective review of unintentional pediatric ingestions of doxylamine That relatively reassuring outcome in toddlers should not breed complacency. Intentional overdoses in adolescents paint a far grimmer picture: one reported case involved a 17-year-old who took 48 Unisom SleepTabs (1.2 grams of doxylamine) along with other medications and presented with seizure-like activity, altered consciousness, rapid heart rate, and QRS widening on her ECG.10Pediatric Emergency Medicine Journal. An adolescent case of doxylamine-induced widening of QRS complex Keeping sleep aids stored safely out of reach matters for every age group in the household.
Unisom During Pregnancy
Pregnant people searching “how many Unisom can I take” are often dealing with morning sickness rather than insomnia. Doxylamine combined with vitamin B6 (pyridoxine) is actually a first-line pharmacological treatment for nausea and vomiting in pregnancy. The FDA approved a delayed-release combination pill containing 10 mg of doxylamine and 10 mg of pyridoxine (sold as Diclegis, now marketed as Bonjesta in an extended-release form) and classified it as Pregnancy Category A, one of the few drugs to receive that designation, reflecting a substantial accumulated safety record.11PubMed Central. Doxylamine succinate-pyridoxine hydrochloride (Diclegis) for the management of nausea and vomiting in pregnancy
Many pregnant people use over-the-counter Unisom SleepTabs (25 mg doxylamine) cut in half and paired with a B6 supplement as a cheaper alternative to the prescription product. This is a widespread practice and one that many obstetricians explicitly recommend. But the dosing for morning sickness differs from the insomnia dose. Typical guidance for nausea is half a 25 mg tablet (12.5 mg) taken with 25 mg of B6, up to three or four times per day, which means the total daily doxylamine intake can reach 37.5 to 50 mg spread across multiple smaller doses. That is more doxylamine than the single 25 mg insomnia dose, but it is taken in smaller increments throughout the day and has been studied extensively in that context. You should still follow your healthcare provider’s specific instructions rather than designing your own regimen.
Why Older Adults Should Be Extra Cautious
First-generation antihistamines appear on the American Geriatrics Society’s Beers Criteria, a widely used list of medications considered potentially inappropriate for older adults. The reasons are practical. As you age, your body clears these drugs more slowly, so a single 25 mg dose of doxylamine hangs around longer and produces stronger anticholinergic effects. Those effects are also more consequential in an older person: confusion and unsteadiness raise the risk of falls, and blurred vision and urinary retention are more than just nuisances for someone already dealing with age-related changes.
The cognitive concern goes beyond a foggy morning. Anticholinergic medications carry an increased risk of worsening cognition, and research on patients with dementia has found that those taking anticholinergic drugs showed greater functional decline over one year compared to those who were not, even when their cognitive test scores were similar.12PubMed Central. Does anticholinergic medication use on presentation to a rural memory clinic predict cognitive or functional decline over one year? And a large nationally representative study found that routinely using sleep medication was associated with about a 30 percent higher risk of developing dementia over follow-up.13PubMed Central. Sleep medication use and incident dementia in a nationally representative sample of older adults in the US Whether the sleep medications caused the dementia or whether both were driven by something else remains debated, but the association is strong enough that most geriatric specialists actively discourage routine use of these drugs in older patients.
The Two-Week Rule and Why It Exists
Unisom’s label advises you to see a doctor if your insomnia lasts longer than two weeks. This is not just legal boilerplate. The recommendation traces back to a 1983 NIH consensus conference that advised against using sleep medications for more than about three weeks, a guideline that regulatory agencies eventually baked into OTC labeling requirements.14PubMed Central. Long-Term Use of Insomnia Medications: An Appraisal of the Current Clinical and Scientific Evidence The reasoning is straightforward: short-term insomnia usually has a trigger (stress, jet lag, a schedule change) and resolves on its own or with brief help. Insomnia lasting longer than two weeks is more likely to be chronic, and chronic insomnia responds better to behavioral approaches like stimulus control and sleep restriction than to nightly antihistamine use.
Many people ignore this guideline and take Unisom nightly for months or years. Aside from the tolerance problem and the cognitive side effects already discussed, long-term nightly use can create rebound insomnia when you try to stop. Because your brain adjusts to the drug’s constant presence, withdrawal often produces a few nights of sleep that feels even worse than your original insomnia, which can convince you that you “need” the drug. Tapering gradually rather than stopping abruptly usually makes the transition easier.
Why the Same Dose Hits People Differently
You might wonder why your friend takes one Unisom and sleeps like a rock while you take the same tablet and lie awake for another hour or wake up feeling drugged until noon. Part of the answer is genetic variation in the liver enzymes responsible for breaking these drugs down. Diphenhydramine, for example, is primarily metabolized by the enzyme CYP2D6, with contributions from CYP1A2, CYP2C9, and CYP2C19.15American Society for Pharmacology and Experimental Therapeutics (ASPET) / Drug Metabolism and Disposition. Identification of Human Cytochrome P450 Isozymes Involved in Diphenhydramine N-Demethylation CYP2D6 is famously variable across the population: some people carry gene variants that make them ultra-rapid metabolizers who burn through the drug quickly, while others are poor metabolizers who clear it slowly and feel the effects far longer. Doxylamine follows a similar metabolic pathway. This means that a standard 25 mg dose could behave like a much larger or much smaller dose depending on your individual enzyme profile.
Body weight, age, other medications, and liver health also affect clearance. Combining Unisom with alcohol, benzodiazepines, opioids, or other sedating drugs amplifies sedation in ways that are difficult to predict and can suppress breathing. The label warnings about not mixing with alcohol are not cautionary suggestions — they reflect a genuine risk of dangerous respiratory depression.
Safer Alternatives When Unisom Stops Working
If you have been relying on Unisom and find yourself tempted to take a second or third tablet, that is a strong signal to step back and rethink your approach rather than escalate the dose. Cognitive behavioral therapy for insomnia (CBT-I) is considered the first-line treatment for chronic insomnia by every major sleep medicine organization. It works at least as well as medications in the short term and better in the long term, without the side effects or rebound insomnia.
For people who prefer or need a supplement-level option, melatonin is a different class of sleep aid. A randomized, placebo-controlled trial of sustained-release melatonin at 2 mg nightly for 28 days found it effective and safe for improving both objective and subjective sleep quality in healthy adults with poor sleep.16PubMed Central. Efficacy and Safety of Sustained-Release Melatonin Capsules (2 mg) in Healthy Adults with Poor Sleep Quality Melatonin works through a completely different mechanism than antihistamines, nudging the body’s circadian clock rather than sedating the brain by force. It does not carry anticholinergic baggage and is generally better tolerated in older adults, though the unregulated supplement market means product quality varies widely.
Prescription options like low-dose trazodone, suvorexant, and lemborexant exist for insomnia that genuinely needs medication, and a sleep specialist can match the right drug to your specific sleep pattern. The point worth keeping in mind is that reaching for a second Unisom tablet is almost never the right next step, and asking a doctor is almost always a better one.